MedFront Medical Technology Corporation to Distribute Leading Closed System Transfer Devices in Taiwan;
PORT WASHINGTON, N.Y., Sept. 23, 2014 /PRNewswire/ — Equashield (http://www.equashield.com/), a leading provider of Closed System Transfer Devices (CSTD) for hazardous drugs, announced today a new exclusive partnership with Taiwanese distributor MedFront Medical Technology Corporation. Equashield’s leading CSTD has been submitted to regulatory bodies in Taiwan, China and other countries for approval as the company continues to expand globally, and throughout the Asia-Pacific region.
"Having tested the EQUASHIELD® closed systems, we are confident that this is the strongest solution in the market," said David Chien, President of MedFront Medical Technology Corporation. "Both we and our customers noted a significant difference in Equashield’s system and look forward to bringing it to hospitals across the region."
Registration of medical devices in Taiwan takes approximately one year. The Taiwan FDA of the Ministry of Health and Welfare will evaluate the EQUASHIELD® system. Upon receiving this registration, Equashield will be cleared for distribution in the Taiwan market. The company has also recently applied to receive CFDA (China Food and Drug Administration) approval. Its devices will be made available to Chinese hospitals and clinics upon receiving clearance by the end of 2015).
"We are pleased to introduce our CSTD to the Taiwan market with MedFront," said Marino Kriheli, Co-Founder of Equashield. "We are confident in this new partnership, as MedFront brings more than a decade of experience and established relationships with healthcare facilities and decision-makers in the region."
Equashield has signed on several new strategic partnerships with distributors globally on the heels of its FDA clearance under the ONB product code. This code specifies that there is no escape of hazardous drug or vapor concentration from the system, no transfer of environmental contaminants into the system, and that it prevents microbial ingress. In particular, Equashield is defined in the FDA labeling as preventing microbial ingress for up to seven days.
Equashield is a leading provider of Closed System Transfer Devices ( CSTD ), clinically proven to protect healthcare professionals from hazardous drug exposure. The company’s flagship device, EQUASHIELD® II covers more routes of exposure than alternative systems by preventing the contamination of syringe plungers and preventing exposure to drug vapor. No CSTD is faster to deploy or easier to use than EQUASHIELD® II. For more information, visit the company’s website at http://www.equashield.com/. Follow Equashield on Twitter: @equashield .
About MedFront Medical Technology Corporation
Located in downtown Taipei, MedFront Medical Technology Corporation was founded in 2000 and is dedicated to the sale of healthcare-related products. The Company’s product line also includes series of medical devices.